Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-01-19 | 2023-01-19 |
| Drug Identification Number | 00664227 | 00664227 |
| Brand name | DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML | DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML |
| Common or Proper name | DEXAMETHASONE 4MG/ML | DEXAMETHASONE 4MG/ML |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | DEXAMETHASONE PHOSPHATE | DEXAMETHASONE PHOSPHATE |
| Strength(s) | 4MG | 4MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR | INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR |
| Packaging size | 5ML | 5ML |
| ATC code | H02AB | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-12-14 | 2022-12-14 |
| Estimated end date | 2023-01-20 | 2023-01-20 |
| Actual end date | 2023-01-18 | 2023-01-18 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |